logo

For the Inventor, By the Inventor

Snyder, NY, United States of America

Lance J Bronnenkant

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Teva Women's Health, Inc., Db Inserters, Inc., Fei Products, Inc.. Active years: 1994-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lance J Bronnenkant. Retrieved from https://idiyas.com/inventor/lance-j-bronnenkant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 105(Granted Patents)


Location History:

  • Synder, NY (US) (2010)
  • Snyder, NY (US) (1994 - 2013)

Company Filing History:

goldMedal2 out of 20 
 
Teva Women's Health, Inc.
 patents
silverMedal1 out of 1 
 
Db Inserters, Inc.
 patent
bronzeMedal1 out of 1 
 
Fei Products, Inc.
 patent
4. 1 out of 2 
 
Teva Woman's Health, Inc.
 patents
5. 1 out of 1 
 
Teva Womans's Health, Inc.
 patent

Years Active: 1994-2013

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8450299 - Methods of hormonal treatment utilizing ascending-dose extended cycle regimens (2013-05-28),
2. 8415332 - Methods of hormonal treatment utilizing ascending-dose extended cycle regimens (2013-04-09),
3. 7855190 - Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration (2010-12-21),
4. 7772219 - Methods of hormonal treatment utilizing extended cycle contraceptive regimens (2010-08-10),
5. 5842474 - IUD loading device (1998-12-01),
6. 5370129 - IUD inserting apparatus (1994-12-06),

Title: **Lance J Bronnenkant: Innovator in Hormonal Treatment**

Introduction

Lance J Bronnenkant, based in Snyder, NY, is a notable inventor recognized for his contributions to the field of hormonal treatment. With a total of six patents accredited to his name, he has made significant advancements aimed at improving women's health and contraceptive options.

Latest Patents

Among his recent innovations, Lance has developed methods for hormonal treatment utilizing ascending-dose extended cycle regimens. This invention involves administering estrogen and progestin to females for a period exceeding 30 or 31 consecutive days. The regimen may optionally include a hormone-free interval or a period of estrogen administration. These innovative treatments can provide both contraceptive and non-contraceptive benefits for women.

Career Highlights

Throughout his career, Lance J Bronnenkant has collaborated with leading companies such as Teva Women's Health, Inc. and Teva Woman's Health, Inc. His role in these organizations has allowed him to work on projects that are pivotal in the advancement of women's health solutions.

Collaborations

Lance has worked alongside notable colleagues in his field, including Kathleen Z Reape and Charles E DiLiberti. These collaborations have been essential in fostering innovative approaches in hormonal treatment and enhancing the efficacy of related therapies.

Conclusion

Lance J Bronnenkant continues to be a prominent figure in innovation related to hormonal treatments. His ongoing work not only demonstrates his commitment to women's health but also represents significant contributions to the medical industry through his patented inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…